RATIOS
Jagsonpal Pharmaceuticals Ltd.
BSE
Jun 16, 04:01
231.20
-1.85 ( -0.79%)
Volume
5463
Prev. Close
233.05
Open Price
230.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 16, 03:49
231.09
-1.86 ( -0.80%)
Volume
74474
Prev. Close
232.95
Open Price
230.61
Bid Price(Qty.)
231.09 (200)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE048B01035
|
Market Cap. ( ₹ in Cr. )
|
1537.36
|
P/BV
|
7.80
|
Book Value ( ₹ )
|
29.64
|
|
BSE Code
|
507789
|
52 Week High/Low ( ₹ )
|
328/130
|
FV/ML
|
2/1
|
P/E(X)
|
27.77
|
|
NSE Code
|
JAGSNPHARMEQ
|
Book Closure
|
08/01/2025
|
EPS ( ₹ )
|
8.32
|
Div Yield (%)
|
1.08
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 8.26 | 8.49 | 10.20 | 7.48 | 6.51 |
| Diluted EPS (Rs.) | 8.22 | 8.46 | 10.20 | 7.48 | 6.51 |
| Cash EPS (Rs.) | 9.56 | 9.13 | 10.66 | 8.06 | 6.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.14 | 70.88 | 60.65 | 46.96 | 43.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.14 | 70.88 | 60.65 | 49.95 | 46.54 |
| Dividend / Share (Rs.) | 2.50 | 5.00 | 5.00 | 4.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 40.47 | 78.94 | 90.36 | 86.30 | 71.74 |
| PBDIT / Share (Rs.) | 8.92 | 12.23 | 15.22 | 11.12 | 8.96 |
| PBIT / Share (Rs.) | 7.70 | 11.61 | 14.76 | 10.54 | 8.76 |
| PBT / Share (Rs.) | 10.52 | 11.30 | 13.29 | 10.43 | 8.35 |
| Net Profit / Share (Rs.) | 8.34 | 8.50 | 10.20 | 7.48 | 6.51 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 22.05 | 15.49 | 16.84 | 12.88 | 12.48 |
| PBIT Margin (%) | 19.02 | 14.70 | 16.34 | 12.20 | 12.21 |
| PBT Margin (%) | 25.99 | 14.31 | 14.70 | 12.08 | 11.63 |
| Net Profit Margin (%) | 20.60 | 10.76 | 11.28 | 8.66 | 9.07 |
| Return on Networth / Equity (%) | 23.07 | 11.98 | 16.81 | 15.92 | 14.95 |
| Return on Capital Employeed (%) | 20.26 | 15.50 | 23.10 | 20.55 | 18.54 |
| Return On Assets (%) | 19.89 | 10.34 | 13.70 | 11.62 | 10.38 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Asset Turnover Ratio (%) | 1.08 | 1.01 | 1.30 | 1.36 | 1.21 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 6.22 | 10.42 | 5.97 | 3.24 | 2.98 |
| Quick Ratio (X) | 5.64 | 9.63 | 5.22 | 2.37 | 2.25 |
| Inventory Turnover Ratio (X) | 1.21 | 1.24 | 1.24 | 1.36 | 1.31 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 58.31 | 0.00 | 53.50 | 15.35 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 54.29 | 0.00 | 49.63 | 14.91 |
| Earning Retention Ratio (%) | 0.00 | 41.69 | 0.00 | 46.50 | 84.65 |
| Cash Earning Retention Ratio (%) | 0.00 | 45.71 | 0.00 | 50.37 | 85.09 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 61.86 | 39.74 | 96.57 | 102.18 | 21.61 |
| Interest Coverage Ratio (Post Tax) (%) | 38.24 | 28.60 | 74.08 | 69.70 | 16.71 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1305.18 | 591.93 | 644.85 | 795.42 | 154.96 |
| EV / Net Operating Revenue (X) | 4.86 | 2.84 | 2.72 | 3.52 | 0.82 |
| EV / EBITDA (X) | 22.02 | 18.30 | 16.17 | 27.31 | 6.60 |
| MarketCap / Net Operating Revenue (X) | 5.34 | 3.54 | 3.21 | 3.63 | 1.11 |
| Retention Ratios (%) | 0.00 | 41.68 | 0.00 | 46.49 | 84.64 |
| Price / BV (X) | 5.98 | 3.95 | 4.78 | 6.68 | 1.83 |
| Price / Net Operating Revenue (X) | 5.34 | 3.54 | 3.21 | 3.63 | 1.11 |
| EarningsYield | 0.03 | 0.03 | 0.03 | 0.02 | 0.08 |